Masahiro Tohkin
Nagoya City University
56 Papers
243 Citations
Masahiro Tohkin is an academic researcher from Nagoya City University. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 14, co-authored 55 publications.
Chat about Author
Papers
Cross-Classification of Human Urinary Lipidome by Sex, Age, and Body Mass Index.
TL;DR: It is suggested that sex, but neither ages nor BMI could be a confounding factor for measuring the composition of urinary lipid metabolites in the healthy population.
Development of a detection algorithm for statin-induced myopathy using electronic medical records.
Kimie Sai,Tadaaki Hanatani,Yu-ichiro Azuma,Katsunori Segawa,Masahiro Tohkin,H. Omatsu,H. Makimoto,Midori Hirai,Yoshiro Saito +8 more
TL;DR: This study aimed to develop a detection algorithm, highly selective for SIM using EMRs, which should enable accurate estimation of adverse drug event frequencies and thus promote appropriate regulatory actions.
Thyroid hormone receptor mediates human MDR1 gene expression-Identification of the response region essential for gene expression.
TL;DR: It is demonstrated that the thyroid hormone receptor (TR) induces MDR1 gene expression in a thyroid hormone (TH)-dependent manner and two closely spaced TR/RXR-binding clusters are both required for the maximal induction of MDR 1 gene expression mediated by TR.
Expression, mutation, and methylation of cereblon‐pathway genes at pre‐ and post‐lenalidomide treatment in multiple myeloma
Takuto Tachita,Takuto Tachita,Shiori Kinoshita,Masaki Ri,Sho Aoki,Arisa Asano,Takashi Kanamori,Takashi Yoshida,Takashi Yoshida,Haruhito Totani,Asahi Ito,Shigeru Kusumoto,Hirokazu Komatsu,Kazufumi Yamagata,Kohmei Kubo,Masahiro Tohkin,Shinsaku Fukuda,Shinsuke Iida +17 more
TL;DR: In conclusion, a decreased expression of IKZF1 and increased expression of KPNA2 compared to that of CRBN mRNA predicts poor outcomes of Ld therapy.
Significant Association between Hand-Foot Syndrome and Efficacy of Capecitabine in Patients with Metastatic Breast Cancer
Yu-ichiro Azuma,Kojiro Hata,Kimie Sai,Ryoko Udagawa,Akihiro Hirakawa,Masahiro Tohkin,Yasuaki Ryushima,Yoshinori Makino,Nobuaki Yokote,Norifumi Morikawa,Yasuhiro Fujiwara,Yoshiro Saito,Hiroshi Yamamoto +12 more
TL;DR: A significant correlation between HFS and some efficacy markers of capecitabine therapy in patients with metastatic breast cancer is clearly showed, and suggests that early dose adjustment based on severity of HFS might improve efficacy.